Skip to main content
Erschienen in: AIDS and Behavior 5/2015

01.05.2015 | Original Paper

Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy

verfasst von: C. E. Newman, J. de Wit, A. Persson, M. Holt, S. Slavin, M. R. Kidd, J. J. Post, E. Wright, L. Mao

Erschienen in: AIDS and Behavior | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

The use of antiretroviral therapy to prevent HIV transmission is now advocated in many settings, yet little research has documented the views of people with HIV. Semi-structured interviews were conducted in Australia between 2012 and 2014 with 27 HIV-positive people not using treatment at the time of interview. Thematic analysis of views on treatment-as-prevention found that while many participants recognised potential prevention benefits, only a minority was in support of initiating treatment solely to achieve those benefits. A range of uncertain or critical views were expressed regarding who would benefit, risk reduction, and changing treatment norms. Participants resisted responsibility narratives that implied treatment should be used for the public good, in favour of making considered decisions about their preferred approach to managing HIV. Engaging communities in dialogue and debate regarding the risks and benefits of treatment will be critical if this new prevention strategy is to engender public trust.
Literatur
2.
Zurück zum Zitat Velasco-Hernandez JX, Gershengorn HB, Blower SM. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis. 2002;2(8):487–93.CrossRefPubMed Velasco-Hernandez JX, Gershengorn HB, Blower SM. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis. 2002;2(8):487–93.CrossRefPubMed
3.
4.
Zurück zum Zitat Rodger A, Bruun T, Cambiano V, et al. Abstract 153LB: HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER study. Conference on Retroviruses and Opportunistic Infections 2014. Boston, USA 2014. Rodger A, Bruun T, Cambiano V, et al. Abstract 153LB: HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER study. Conference on Retroviruses and Opportunistic Infections 2014. Boston, USA 2014.
5.
Zurück zum Zitat Miller WC, Powers KA, Smith MK, Cohen MS. Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis. 2013;13(5):459–64.CrossRefPubMed Miller WC, Powers KA, Smith MK, Cohen MS. Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis. 2013;13(5):459–64.CrossRefPubMed
7.
10.
Zurück zum Zitat Mayer K, Beyrer C. WHO’s new HIV guidelines: opportunities and challenges. Lancet. 2013;382(9889):287–8.CrossRefPubMed Mayer K, Beyrer C. WHO’s new HIV guidelines: opportunities and challenges. Lancet. 2013;382(9889):287–8.CrossRefPubMed
17.
Zurück zum Zitat Mao L, Adam P, Kippax S, et al. The evolving views and practices of antiretroviral treatment (ART) prescribers in Australia. Med J Aust [in press]. Mao L, Adam P, Kippax S, et al. The evolving views and practices of antiretroviral treatment (ART) prescribers in Australia. Med J Aust [in press].
18.
Zurück zum Zitat Whittaker B. Transforming Australia’s HIV prevention and treatment efforts to achieve an AIDS-free generation: the United Nations Political Declaration on HIV/AIDS and the Melbourne Declaration ‘Action on HIV’. Sex Health. 2014;11(2):101–6.PubMed Whittaker B. Transforming Australia’s HIV prevention and treatment efforts to achieve an AIDS-free generation: the United Nations Political Declaration on HIV/AIDS and the Melbourne Declaration ‘Action on HIV’. Sex Health. 2014;11(2):101–6.PubMed
19.
Zurück zum Zitat Kulkarni SP, Shah KR, Sarma KV, Mahajan AP. Clinical uncertainties, health service challenges, and ethical complexities of HIV ‘test-and-treat’: a systematic review. Am J Public Health. 2013;103(6):e14–23.CrossRefPubMed Kulkarni SP, Shah KR, Sarma KV, Mahajan AP. Clinical uncertainties, health service challenges, and ethical complexities of HIV ‘test-and-treat’: a systematic review. Am J Public Health. 2013;103(6):e14–23.CrossRefPubMed
20.
Zurück zum Zitat Bassett MT, Brudney K. WHO’s new guidelines for antiretroviral treatment. Lancet. 2013;382(9907):1777–8.CrossRefPubMed Bassett MT, Brudney K. WHO’s new guidelines for antiretroviral treatment. Lancet. 2013;382(9907):1777–8.CrossRefPubMed
21.
Zurück zum Zitat Cohen MS, Muessig KE, Smith MK, Powers KA, Kashuba ADM. Antiviral agents and HIV prevention: controversies, conflicts, and consensus. AIDS. 2012;26(13):1585–98.CrossRefPubMedCentralPubMed Cohen MS, Muessig KE, Smith MK, Powers KA, Kashuba ADM. Antiviral agents and HIV prevention: controversies, conflicts, and consensus. AIDS. 2012;26(13):1585–98.CrossRefPubMedCentralPubMed
22.
Zurück zum Zitat Kippax S, Stephenson N. Beyond the distinction between biomedical and social dimensions of hiv prevention through the lens of a Social Public Health. Am J Public Health. 2012;102(5):789–99.CrossRefPubMedCentralPubMed Kippax S, Stephenson N. Beyond the distinction between biomedical and social dimensions of hiv prevention through the lens of a Social Public Health. Am J Public Health. 2012;102(5):789–99.CrossRefPubMedCentralPubMed
24.
Zurück zum Zitat Imrie J, Elford J, Kippax S, Hart GJ. Biomedical HIV prevention—and social science. Lancet 2007;370(9581):10–11. Imrie J, Elford J, Kippax S, Hart GJ. Biomedical HIV prevention—and social science. Lancet 2007;370(9581):10–11.
25.
Zurück zum Zitat Haire B, Kaldor JM. Ethics of ARV based prevention: treatment-as-prevention and PrEP. Dev World Bioeth. 2013;13(2):63–9.CrossRefPubMed Haire B, Kaldor JM. Ethics of ARV based prevention: treatment-as-prevention and PrEP. Dev World Bioeth. 2013;13(2):63–9.CrossRefPubMed
26.
Zurück zum Zitat Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195–216.CrossRefPubMedCentralPubMed Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195–216.CrossRefPubMedCentralPubMed
27.
Zurück zum Zitat Holt M. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas. Sex Health. 2014;11(2):166–70.PubMed Holt M. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas. Sex Health. 2014;11(2):166–70.PubMed
28.
Zurück zum Zitat Holt M, Murphy D, Callander D, et al. HIV-negative and HIV-positive gay men’s attitudes to medicines, HIV treatments and antiretroviral-based prevention. AIDS Behav. 2013;17(6):2156–61.CrossRefPubMed Holt M, Murphy D, Callander D, et al. HIV-negative and HIV-positive gay men’s attitudes to medicines, HIV treatments and antiretroviral-based prevention. AIDS Behav. 2013;17(6):2156–61.CrossRefPubMed
29.
Zurück zum Zitat Down I, Prestage G, Triffitt K, Brown G, Bradley J, Ellard J. Recently diagnosed gay men talk about HIV treatment decisions. Sex Health. 2014;11(2):200–6.PubMed Down I, Prestage G, Triffitt K, Brown G, Bradley J, Ellard J. Recently diagnosed gay men talk about HIV treatment decisions. Sex Health. 2014;11(2):200–6.PubMed
31.
Zurück zum Zitat Colvin CJ, Robins S, Leavens J. Grounding ‘responsibilisation talk’: masculinities, citizenship and HIV in Cape Town, South Africa. J Dev Stud. 2010;46(7):1179–95.CrossRefPubMed Colvin CJ, Robins S, Leavens J. Grounding ‘responsibilisation talk’: masculinities, citizenship and HIV in Cape Town, South Africa. J Dev Stud. 2010;46(7):1179–95.CrossRefPubMed
32.
Zurück zum Zitat Beckmann N. Responding to medical crises: AIDS treatment, responsibilisation and the logic of choice. Anthrop Med. 2013;20(2):160–74.CrossRef Beckmann N. Responding to medical crises: AIDS treatment, responsibilisation and the logic of choice. Anthrop Med. 2013;20(2):160–74.CrossRef
33.
Zurück zum Zitat Petersen A, Davis M, Fraser S, Lindsay J. Healthy living and citizenship: an overview. Crit Publ Health. 2010;20(4):391–400.CrossRef Petersen A, Davis M, Fraser S, Lindsay J. Healthy living and citizenship: an overview. Crit Publ Health. 2010;20(4):391–400.CrossRef
34.
Zurück zum Zitat Race K. The undetectable crisis: changing technologies of risk. Sexualities. 2001;4(2):167–189. Race K. The undetectable crisis: changing technologies of risk. Sexualities. 2001;4(2):167–189.
35.
Zurück zum Zitat Pound P, Britten N, Morgan M, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.CrossRefPubMed Pound P, Britten N, Morgan M, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.CrossRefPubMed
38.
Zurück zum Zitat Newman CE, de Wit JBF, Crooks L, Reynolds RH, Canavan PG, Kidd MR. Challenges of providing HIV care in general practice. Aust J Prim Health [in press]. Newman CE, de Wit JBF, Crooks L, Reynolds RH, Canavan PG, Kidd MR. Challenges of providing HIV care in general practice. Aust J Prim Health [in press].
39.
Zurück zum Zitat Bryman A. Social research methods. 4th ed. Oxford: Oxford University Press; 2012. Bryman A. Social research methods. 4th ed. Oxford: Oxford University Press; 2012.
41.
Zurück zum Zitat Mishler EG. Patient stories, narratives of resistance and the ethics of humane care. Health. 2005;9(4):431–51.PubMed Mishler EG. Patient stories, narratives of resistance and the ethics of humane care. Health. 2005;9(4):431–51.PubMed
42.
Zurück zum Zitat Collins S, Geffen N. Community views: balancing the public health benefits of earlier antiretroviral treatment with the implications for individual patients—perspectives from the community. Curr Opin HIV AIDS. 2014;9(1):4–10.CrossRefPubMed Collins S, Geffen N. Community views: balancing the public health benefits of earlier antiretroviral treatment with the implications for individual patients—perspectives from the community. Curr Opin HIV AIDS. 2014;9(1):4–10.CrossRefPubMed
44.
Zurück zum Zitat Hirsch JS. Gender, sexuality, and antiretroviral therapy: using social science to enhance outcomes and inform secondary prevention strategies. AIDS. 2007;21:S21–9.CrossRefPubMed Hirsch JS. Gender, sexuality, and antiretroviral therapy: using social science to enhance outcomes and inform secondary prevention strategies. AIDS. 2007;21:S21–9.CrossRefPubMed
45.
Zurück zum Zitat de Wit JBF, Adam P. Revolution or evolution: What can approaches based on the use of antiretroviral drugs contribute to HIV prevention in gay communities in high income countries? In: Eaton LA, Kalichman SC, eds. Biomedical Advances in HIV Prevention: Social and Behavioral Perspectives: Springer; 2014. pp. 181–204. de Wit JBF, Adam P. Revolution or evolution: What can approaches based on the use of antiretroviral drugs contribute to HIV prevention in gay communities in high income countries? In: Eaton LA, Kalichman SC, eds. Biomedical Advances in HIV Prevention: Social and Behavioral Perspectives: Springer; 2014. pp. 181–204.
47.
Zurück zum Zitat Newman C, Persson A, Ellard J. ‘We just don’t know’: ambivalence about treatment strategies in the Australian community-based HIV media. Health. 2006;10(2):191–210.PubMed Newman C, Persson A, Ellard J. ‘We just don’t know’: ambivalence about treatment strategies in the Australian community-based HIV media. Health. 2006;10(2):191–210.PubMed
Metadaten
Titel
Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy
verfasst von
C. E. Newman
J. de Wit
A. Persson
M. Holt
S. Slavin
M. R. Kidd
J. J. Post
E. Wright
L. Mao
Publikationsdatum
01.05.2015
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 5/2015
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0959-9

Weitere Artikel der Ausgabe 5/2015

AIDS and Behavior 5/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.